EOS imaging Announces Two New US Installations

Regulatory News:

EOS Imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the installation of the EOS imaging system at two new sites in the U.S. The first is at Northwestern Medicine’s new, state-of-the-art, one-million square foot outpatient pavilion. The new pavilion is situated in the heart of Northwestern Medicine’s downtown medical campus, which is home to Northwestern Memorial Hospital and Northwestern University’s Feinberg School of Medicine. The second is at the Spine Center at the University of Virginia Health System, in Charlottesville, VA.

Northwestern Memorial Hospital is one of the country’s premier academic hospitals and a major referral center for the Midwest and beyond. In the 2014 ranking of the nation's "Best Hospitals" published by U.S. News & World Report, Northwestern Memorial is ranked No. 1 in Illinois and the Chicago metro area, and was named to the prestigious honor roll of the nation's top hospitals.

The University of Virginia (UVA) Health System includes a 604-bed hospital, a level I trauma center, and nationally recognized primary and specialty clinics throughout Central Virginia. The UVA Spine Center and Department of Neurosurgery was recently honored by Becker’s Hospital Review on the publication’s 2014 list of 100 hospitals with great neurosurgery and spine programs.

Marie Meynadier, CEO of EOS imaging, said, "Northwestern Medicine and the University of Virginia Health System are well-recognized leading hospitals in the United States, with high-ranking orthopedic programs that serve patients in their communities. We are honored that the EOS® system will be one of the centerpieces of their imaging center. Being part of these leading facilities that are dedicated to orthopedic and spine care is a strong indication that EOS® is becoming an integral component in the orthopedic care process.”

The EOS® system provides full-body stereoradiographic images of patients in functional positions, in both 2D and 3D. With 50% to 85% less dose than Digital Radiology and 95% less dose than basic CT scans, EOS® is fully in accordance with the ALARA (As Low As Reasonably Achievable) principle of radiation reduction.

For further information about the Company or EOS®, the first full body, low dose 2D/3D imaging system, please visit http://www.eos-imaging.com/.

About EOS imaging:

EOS imaging designs, develops, and markets EOS® and associated solutions, an innovative medical imaging system based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Company is authorized to market in 34 countries, including the United States (FDA), Japan and the European Union (EU). As of December 31, 2013 the Group posted 2013 consolidated revenue of €15.2 million and employed 106 people including an R&D team of 38 engineers. The Group is based in Paris and holds four subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada) and Frankfurt (Germany), and offices in Singapore.

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI